Andrew M Bellizzi, M.D.
University of Iowa
H-index: 41
North America-United States
Top articles of Andrew M Bellizzi, M.D.
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A systematic NEN spheroid drug screen reveals a novel drug resistance mechanism in small bowel NETs | Cancer Research | Catherine G Tran Luis C Borbon Dane H Tow Jonathan Shilyansky Guiying Li | 2024/3/22 |
Erythrophagocytosis is not a reproducible finding in liver biopsies, and is not associated with clinical diagnosis of hemophagocytic lymphohistiocytosis | Virchows Archiv | Niyati Desai Satoru Kudose Helen E Remotti Armando Del Portillo Ladan Fazlollahi | 2024/1 |
Principles of Analytic Validation of Immunohistochemical Assays: Guideline Update | Archives of Pathology & Laboratory Medicine | Jeffrey D Goldsmith Megan L Troxell Sinchita Roy-Chowdhuri Carol F Colasacco Mary Elizabeth Edgerton | 2024/2/23 |
Assessment of specificity of dermatopathologic criteria for IgG4‐related skin disease | Journal of cutaneous pathology | Zachary Skopec Mouaz Alsawas Timothy Maxwell Daniel Pelletier Zoe Brown‐Joel | 2024/2 |
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors | CA: A Cancer Journal for Clinicians | Aman Chauhan Kelley Chan Thorvardur R Halfdanarson Andrew M Bellizzi Guido Rindi | 2024 |
Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers | Radiation research | Melissa A Fath Dijie Liu Jordan T Ewald Claudia Robles-Planells Ann M Tomanek-Chalkley | 2024/1/1 |
Surgical management of G3 gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis | Ioannis A Ziogas Panagiotis T Tasoudis Luis C Borbon Scott K Sherman Patrick J Breheny | 2023/1 | |
Erdheim-Chester disease associated with an aggressive form of sclerosing cholangitis | Egyptian Liver Journal | Ruchi Sharma Mary S Stone Donald E Macfarlane Andrew M Bellizzi Gopala Koneru | 2023/2/4 |
Multi-institutional study of pathologist reading of the programmed cell death ligand-1 combined positive score immunohistochemistry assay for gastric or gastroesophageal … | Modern Pathology | Aileen I Fernandez Charles J Robbins Patricia Gaule Diana Agostini-Vulaj Robert A Anders | 2023/5/1 |
Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO Guideline | Journal of clinical oncology | Jaydira Del Rivero Kimberly Perez Erin B Kennedy Erik S Mittra Namrata Vijayvergia | 2023/11/10 |
Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth in vivo | bioRxiv | Dane H Tow Catherine G Tran Luis C Borbon Maclain Ridder Guiying Li | 2023/4/8 |
Altered MANF Expression in Pancreatic Acinar and Ductal Cells in Chronic Alcoholic Pancreatitis: A Cross-Sectional Study | Biomedicines | Nicholas J Caldwell Hui Li Andrew M Bellizzi Jia Luo | 2023/2/2 |
Next-Generation Immunohistochemistry in the Workup of Neoplasm of Uncertain Lineage and CUP | Andrew M Bellizzi | 2023/11/1 | |
Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors | Endocrine Abstracts | Courtney Kaemmer Shaikamjad Umesalma Chandra Maharjan Jordan Kohlmeyer Joshua Lingo | 2023/12/15 |
CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors | Endocrine Abstracts | Courtney Kaemmer Shaikamjad Umesalma Chandra Maharjan Jordan Kohlmeyer Emily Wilkerson | 2023/2/1 |
Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of … | The American journal of surgical pathology | Raymond A Isidro Ibrahim Abukhiran Craig D Dunseth Matthew D Gosse Robert M Humble | 2023/4/1 |
Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma | Archives of pathology & laboratory medicine | Ian S Hagemann Julia A Bridge Laura J Tafe Meera R Hameed Joel T Moncur | 2023/10/1 |
Peptide receptor radionuclide therapy improves survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors | Endocrine Abstracts | Luis C Borbon Scott K Sherman Patrick Breheny Po H Ear Yusuf Menda | 2023/12/15 |
Using American Type Culture Collection Cell Lines to Evaluate Interlaboratory Variables for Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Immunostaining | Archives of Pathology & Laboratory Medicine | Benjamin L Witt Wenhua Zhou Abiy B Ambaye Andrew Bellizzi Christine N Booth | 2023/2/1 |
Practice patterns for reporting digestive system neuroendocrine neoplasms: results from a large, comprehensive international survey | Histopathology | Dipti M Karamchandani Brian Cox Stefano La Rosa Andrew M Bellizzi Chanjuan Shi | 2023/3 |
Co-Authors
